Biora Therapeutics Newsroom

Biora Therapeutics Analyst Ratings

BenzingaNov 18 12:59 ET

Biora Therapeutics Analyst Ratings

BenzingaJul 22 06:43 ET

Biora Therapeutics Buy Rating Confirmed by Positive Phase 1 Trial Outcomes and NaviCap Technology Potential

TipRanksJul 22 06:17 ET

Biora Therapeutics Analyst Ratings

BenzingaMay 16 11:50 ET

Biora Therapeutics Receives Buy Rating Amid Positive Clinical Progress and Promising Drug Delivery Innovations

TipRanksApr 9 06:40 ET

Analysts' Top Healthcare Picks: Biora Therapeutics (BIOR), Irhythm Technologies (IRTC)

TipRanksJan 9 06:30 ET

BTIG Keeps Their Buy Rating on Biora Therapeutics (BIOR)

TipRanksJan 7 05:28 ET

HC Wainwright & Co. Reiterates Buy on Biora Therapeutics, Maintains $50 Price Target

BenzingaJan 2 12:11 ET

Biora Therapeutics Analyst Ratings

BenzingaJan 2 12:09 ET

Biora Therapeutics (BIOR) Receives a Buy From BTIG

TipRanksDec 31, 2023 05:07 ET

Analysts Offer Insights on Healthcare Companies: Biora Therapeutics (BIOR), Bolt Biotherapeutics (BOLT) and Immunovant (IMVT)

TipRanksOct 24, 2023 06:20 ET

HC Wainwright & Co. Maintains Buy on Biora Therapeutics, Lowers Price Target to $50

BenzingaOct 2, 2023 07:01 ET

Biora Therapeutics Analyst Ratings

BenzingaOct 2, 2023 06:56 ET

Analysts Offer Insights on Healthcare Companies: Lyra Therapeutics (LYRA), Omega Therapeutics (OMGA) and Biora Therapeutics (BIOR)

TipRanksOct 2, 2023 06:32 ET

Biora Therapeutics Analyst Ratings

BenzingaAug 15, 2023 06:46 ET

Analysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH), Clearside Biomedical (CLSD) and Biora Therapeutics (BIOR)

TipRanksAug 15, 2023 06:40 ET

HC Wainwright & Co. Reiterates Buy on Biora Therapeutics, Maintains $65 Price Target

BenzingaJul 27, 2023 12:40 ET

Biora Therapeutics Analyst Ratings

BenzingaJul 27, 2023 12:39 ET

H.C. Wainwright Sticks to Its Buy Rating for Biora Therapeutics (BIOR)

TipRanksJul 27, 2023 11:55 ET

H.C. Wainwright Remains a Buy on Biora Therapeutics (BIOR)

TipRanksMay 16, 2023 06:15 ET